Cutaneous toxicity is the most common, followed by immune pneumonia, hypothyroidism, joint and muscle pain.PD-L1 inhibitor has a higher overall incidence of colitis.Myocarditis, immune nephritis and pituitary inflammation are rare yet serious. This evidence concerns the gene CD274 and hypothyroidism.